Article
Promyelocytic leukemia protein promotes the phenotypic switch of smooth muscle cells in atherosclerotic plaques of human coronary arteries.
Clinical science (London, England : 1979) - 16 Apr 2021
Karle Weronika, Becker Samuel, Stenzel Philipp, Knosalla Christoph, Siegel Günter, Baum Oliver, Zakrzewicz Andreas, Berkholz Janine
Abstract excerpt
Promyelocytic leukemia protein (PML) is a constitutive component of PML nuclear bodies (PML-NBs), which function as stress-regulated SUMOylation factories. Since PML can also act as a regulator of the inflammatory and fibroproliferative responses characteristic of atherosclerosis, we investigated whether PML is implicated in this disease. Immunoblotting, ELISA and immunohistochemistry showed a stronger expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
